Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2009
11/18/2009CN101580834A Human 5-HT7 receptor promoter sequence
11/18/2009CN101580833A SiRNA for inhibiting rat Atpase a3 gene expression, recombinant slow virus and application in medicament for treating bone absorption abnormal diseases
11/18/2009CN101580832A Method for separating chromosomes in plant cells by using fluorescence in-situ hybridization
11/18/2009CN101580831A Method for amplifying heavy chain leader sequence of antibody and variable region gene sequence and primer thereof
11/18/2009CN101580830A Soil nematode DNA extraction method
11/18/2009CN101580829A Gene site-directed multi-site mutation method
11/18/2009CN101580828A Nuclear transfer method
11/18/2009CN101580827A Encoding genes of key enzyme, namely chalcone isomerase in metabolic pathway of plant flavonoids
11/18/2009CN101580822A ADP-glucose pyrophosphorylase mutant, encoding genes thereof and application of same two
11/18/2009CN101580820A Encoding genes of key enzyme, namely dihydroflavonol-4-reductase in metabolic pathway of plant anthocyanin
11/18/2009CN101580819A Encoding genes of key enzyme, namely chalcone synthase formed by plant anthocyanin
11/18/2009CN101580815A Omega-amino carboxylic acids, omega-amino carboxylic acid esters, or recombinant cells which produce lactams thereof
11/18/2009CN101580547A HASylated polypeptides, especially HASylated erythropoietin
11/18/2009CN101580546A Human anti human interferon alpha antibody and application thereof
11/18/2009CN101580543A Transcription factor, namely MYB encoding genes synthesized by plant regulatory anthocyanin
11/18/2009CN101580542A Application of mycobacterium tuberculosis adhesion HBHA in diagnosing and treating tuberculosis
11/18/2009CN101580541A Infectious pancreatic necrosis recombinant VP2 protein antigen and purification method
11/18/2009CN101580540A Mouse HCV (hepatitis C virus) polypeptide epitope combined with MHC-I molecule and application thereof
11/18/2009CN101580538A WT1-origin HLA-DR-binding antigen peptide
11/18/2009CN101580537A Human cytomegalovirus UL 49 gene antigenic peptide, antibody thereof and use thereof
11/18/2009CN101579529A Oligonucleotide compositions and method for treating disease including inflammatory conditions
11/18/2009CN101579527A HLA Specific human cytomegalovirus Multi-epitope adenovirus DNA Vaccine of Chinese population
11/18/2009CN101579521A Abortus Chlamydia psittaci vaccine and preparation method thereof
11/18/2009CN101579362A Compositions and method for tumor-target delivery of effect molecules
11/18/2009CN101579351A Application of ACL on sieving drugs for preventing obesity-related metabolic disturbance diseases
11/18/2009CN100561228C Anti-mark antibody chip for protein interaction analysis
11/18/2009CN100560733C Parallel or antiparallel, homologous or complementary binding nucleic acids
11/18/2009CN100560727C Biocatalyst for producing d-lactic acid
11/18/2009CN100560726C Method for selecting genetically transformed cells
11/18/2009CN100560725C Method for quickly constructing siRNA carrier by using pSilencer plasmid
11/18/2009CN100560724C Method for the selection of recombinant clones comprising a sequence encoding an antidote protein to a toxic molecule
11/18/2009CN100560723C Recombinant human sCTLA4-Ig fusion protein gene and its medicinal composition
11/18/2009CN100560720C Methods of delivery of exogenous proteins to the cytosol and uses thereof
11/18/2009CN100560719C MELAN-A peptide analogue-virus-like-particle conjugates
11/18/2009CN100560131C Antibody targeting compounds
11/17/2009US7619153 Plants and seeds or corn variety CV024085
11/17/2009US7619152 Plants and seeds of corn variety CV341132
11/17/2009US7619151 Plants and seeds of corn variety CV614443
11/17/2009US7619150 Plants and seeds of corn variety CV227310
11/17/2009US7619149 Maize variety PHWSF
11/17/2009US7619147 Plants and seeds of corn variety CV449242
11/17/2009US7619146 Stimulating root growth via introducing cytokinin oxidase protein sequences; point mutations
11/17/2009US7619145 Cotton variety 03Y056
11/17/2009US7619144 Cotton variety 02T15
11/17/2009US7619143 Soybean variety D4223057
11/17/2009US7619142 Soybean variety D4102536
11/17/2009US7619141 Soybean variety D4825495
11/17/2009US7619140 Soybean variety D4659251
11/17/2009US7619139 Soybean variety D4572906
11/17/2009US7619138 Specific genetic elements are rearranged in vitro and inserted back into individual plant cells; potato plants display improved tuber storage and health characteristics
11/17/2009US7619137 Transgenic plant cell comprising expression vector coding regulatory protein for use in enhancement of drought resistant plants
11/17/2009US7619136 Transgenic plant with glycosyltransferase gene; converts glucosylceramide present in the plant into lactosylceramide and eventually to ceramide trihexoside
11/17/2009US7619135 DNA comprises the nucleotide sequences used for gene expression of foreign proteins in seeds; genetic engineering
11/17/2009US7619134 Transgenic plant or plant part producing the starch, flour and a thickened foodstuff prepared from a grain capable of producing such isolated starch; modification of amylose content
11/17/2009US7619133 Making transgenic maize seeds resistant to colletotrichum infection; disease resistant plants; stalk rot, leaf blight and top dieback in corn and other cereals
11/17/2009US7619105 Modified cottonseed oil
11/17/2009US7619081 Short interference RNA duplexes when introduced into mammalian cells in culture perform sequence-specific inhibition of target mRNA without inducing an interferon response; for gene silencing to treat human diseases; double stranded siRNA
11/17/2009US7619080 Oligonucleotides of a chicken leukemia inhibitory factor (LIF) gene
11/17/2009US7619078 T cell costimulatory molecule genes; used to identify components of the signal transduction pathway induced in a cell
11/17/2009US7619077 Pectin biosynthetic glycosyltransferase gene isolated from plants; useful to produce in vitro modified pectins of commercial value; transgenic plants
11/17/2009US7619066 IL-1ra variants
11/17/2009US7619065 Cystine-knot fold protein
11/17/2009US7619063 Chimeric protein including a protein from parainfluenza virus and a protein from respiratory syncytial virus, capable of protecting infants and similar susceptible individuals against diseases caused by both parainfluenza virus (PIV) and respiratory syncytial virus (RSV); vaccines
11/17/2009US7619061 Antigen constructs useful in the detection and differentiation of antibodies to HIV
11/17/2009US7619057 Cancer antigen peptide and/or major histocompatibility complex binding sites for use as tools in detection and tretment of cell proliferative disorders; immunotherapy; genetic vaccine
11/17/2009US7618948 Brain delivery of small interfering RNA or vectors containing the DNA encoding for small interfering RNA; beneficial effects on improving memory and/or cognitive function in a subject.
11/17/2009US7618943 Fusion polypeptides, and use thereof in antivascular tumor therapy
11/17/2009US7618942 Controlling insects by contacting with insecticidal Bacillus thuringiensis hybrid protein comprising domains I and II of first native B. thuringiensis delta-endotoxin Cry1A protein, domain III of second native B. thuringiensis delta-endotoxin Cry1F protein, and protoxin segment of native delta endotoxin
11/17/2009US7618941 Treating degenerative joint disorders with tribonectins
11/17/2009US7618939 Isolated azurin or residues from Pseudomonas aeruginosa; inhibiting development of premalignant lesions; expression vectors; kits
11/17/2009US7618819 Use of pseudogene insertion sites to create novel traits in transgenic organisms
11/17/2009US7618818 Method for detecting leptin receptor ligands
11/17/2009US7618816 Metal-binding therapeutic peptides
11/17/2009US7618815 Viral vectors useful in soybean and methods of use
11/17/2009US7618814 Microrna-related nucleic acids and uses thereof
11/17/2009US7618804 Method for producing L-amino acid using bacteria belonging to the genus Escherichia
11/17/2009US7618803 Transgenic gramnegative bacteria for use as bioreactor in for fermentation of threonine and/or valine for use in medicine, cosmetics and animal feeds
11/17/2009US7618802 Compositions of coronaviruses with a recombination-resistant genome
11/17/2009US7618800 Glycerol kinase, which has high resistance against preservative
11/17/2009US7618799 Expression vector comprising nucleotoide sequences coding signal sequences which direct proteins to periplasmic compartment; improving exogenous expression of heterologous polypeptides
11/17/2009US7618796 Industrially producing dipeptides easily and inexpensively without going through a complex synthesis; allowing a protein having proline iminopeptidase activity to act on an L-amino acid ester and an L-amino acid to form the dipeptide
11/17/2009US7618795 Starch process
11/17/2009US7618793 Screening agents for diminishing cellular toxicity associated with alpha-synuclein polypeptide of Parkinson's Disease; Huntington's Disease; inclusion bodies
11/17/2009US7618791 Detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells
11/17/2009US7618787 Method of screening compound capable of accelerating or inhibiting apoptosis, apoptosis accelarator and apoptosis inhibitor
11/17/2009US7618786 Method for identifying modulators of human orexin-2 receptor
11/17/2009US7618785 Diagnostic and therapeutic methods based on the L1 adhesion molecule for ovarian and endometrial tumors
11/17/2009US7618781 Probe sets for detecting MYC-immunoglobulin gene rearrangements
11/17/2009US7618775 Cells comprise orthogonal aminoacyl-tRNA synthetase and p-acetyl-L-phenylalanine; site-directed mutagenesis; kits
11/17/2009US7618774 Materials and methods for identifying genes and/or agents that alter replicative lifespan
11/17/2009US7618773 Selective amplification of a template molecule, especially a nucleic acid
11/17/2009US7618642 Expression cassettes encoding modified human immunodeficiency virus type 1 subtype C envelope glycoproteins
11/17/2009US7618636 Sequences from the bacterium Neisseria meningitidis.
11/17/2009US7618633 Antibodies that bind CD40 and methods of treating cancer and enhancing immune responses
11/17/2009US7618629 Manipulation of cytokine levels using CD83 gene products
11/17/2009US7618628 CD16A binding proteins and use for the treatment of immune disorders
11/17/2009US7618623 Hybrid adeno-retroviral vector for the transfection of cells
11/17/2009CA2447697C Alteration of embryo/endosperm size during seed development
11/17/2009CA2400117C Novel collagen-like protein clac, a precursor thereof, and genes encoding the same
11/17/2009CA2396062C Methods and compositions relating to modulation of hepatocyte growth, plasma cell differentiation or t cell subset activity by modulation of xbp-1 activity
1 ... 1110 1111 1112 1113 1114 1115 1116 1117 1118 1119 1120 1121 1122 1123 1124 1125 1126 1127 1128 1129 1130 ... 4023